韩国帕金森病患者癌症风险:全国性人群队列研究
该研究利用韩国国民健康保险数据库,纳入2010至2015年确诊的52,009例帕金森病患者及260,045例无帕金森病对照,按年龄和性别匹配后随访至2016年。经多变量调整后,帕金森病患者总体癌症风险较低(HR 0.78,95%CI 0.74-0.82),且多种特定癌症风险显著降低。
要点
- 帕金森病患者总体癌症风险低于无帕金森病者(HR 0.78,95%CI 0.74-0.82)。
- 喉癌、胃癌、结直肠癌、肝癌、胰腺癌、肺癌、白血病、宫颈癌和前列腺癌风险显著降低。
- 该结果与近期亚洲研究相反,但与西方研究一致。
核心结论
- 该全国性人群队列研究显示,帕金森病患者总体癌症风险及特定癌症风险均较低。
- 与近期亚洲研究结果相反,该大型队列研究显示韩国帕金森病患者比无帕金森病者更不易患癌症。
- 尽管种族和环境存在差异,该结果与既往西方研究一致。
研究设计与样本
- 全国性人群队列研究,利用韩国国民健康保险数据库数据。
- 纳入2010至2015年确诊的52,009例帕金森病患者和260,045例无帕金森病个体,排除既往诊断为癌症者。
- 按年龄和性别匹配的队列随访至2016年以观察癌症发生,采用Cox比例风险回归模型评估帕金森病与癌症的关系。
主要发现
- 在2,022,852.6人年的随访中,经多变量调整后,帕金森病患者总体癌症风险较低(HR 0.78;95%CI 0.74-0.82)。
- 帕金森病患者喉癌风险显著降低(HR 0.45;95%CI 0.21-0.84)。
- 帕金森病患者胃癌风险显著降低(HR 0.72;95%CI 0.63-0.82)。
- 帕金森病患者结直肠癌风险显著降低(HR 0.675;95%CI 0.60-0.76)。
- 帕金森病患者肝癌风险显著降低(HR 0.80;95%CI 0.67-0.95)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The association between Parkinson's disease (PD) and cancer development is controversial, especially in Asia. Therefore, we conducted a nationwide population-based cohort study to assess the overall cancer risk and risk for specific cancers in patients with PD in Korea. METHODS: Using data from the Korean National Health Insurance Database, we analysed 52,009 patients diagnosed with PD between 2010 and 2015 and 260,045 individuals without PD. Patients previously diagnosed with cancer were excluded. The age- and sex-matched cohorts were followed up until 2016 for cancer development. Cox proportional hazards regression models were used to evaluate the relationship between PD and cancer. RESULTS: Patients with PD had a lower overall cancer risk (hazard ratio [HR], 0.78; 95% confidence interval [CI], 0.74-0.82) after adjustment for multiple covariates during 2,022,852.6 person-years of follow-up. Patients with PD showed significantly lower risk of laryngeal cancer (HR, 0.45; 95% CI, 0.21-0.84), gastric cancer (HR, 0.72; 95% CI, 0.63-0.82), colorectal cancer (HR, 0.675; 95% CI, 0.60-0.76), liver cancer (HR, 0.80; 95% CI, 0.67-0.95), pancreatic cancer (HR, 0.75; 95% CI, 0.62-0.91), lung cancer (HR, 0.73; 95% CI, 0.63-0.84), leukaemia (HR, 0.49; 95% CI, 0.24-0.89), uterine cervical cancer (HR, 0.64; 95% CI, 0.40-0.99) and prostate cancer (HR, 0.78; 95% CI, 0.66-0.91). CONCLUSION: This nationwide population-based cohort study revealed that patients with PD had lower overall cancer risk and lower risk of specific cancers. Contrary to the results of the recent Asian study, this large cohort study revealed that patients with PD were less likely to develop cancer than those without PD in Korea. Our results were consistent with those of previous Western studies, despite differences in ethnicity and environment.
引用
- Park JH, Kim DH, Park YG, et al. Cancer risk in patients with Parkinson's disease in South Korea: A nationwide, population-based cohort study. Eur J Cancer. 2019. PMID: 31229950. doi:10.1016/j.ejca.2019.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。